超越GRADE:重症医学指南的评价
该研究检索2011至2017年美国重症医学会在线发布的全部重症医学临床指南,以及拯救脓毒症运动、肾脏病改善全球结局组织、美国肠外肠内营养学会、美国感染病学会/美国胸科学会各自发布的指南,共15份文件、681条推荐。推荐强度分布为强推荐215条(31.6%)、弱推荐345条(50.7%)、无强度121条(17.8%);证据质量分布为高41条(6.0%)、中等151条(22.2%)、低/极低298条(43.8%)、专家共识/无191条(28.1%)。推荐强度与证据质量正相关(ρ=0.66;p<0.0001)。215条强推荐中69条(32.1%)与高/中等以外证据配对;其中22条(31.9%)为强推荐/专家共识,为GRADE方法所不鼓励;47条(68.1%)为强推荐/低或极低证据,需在五种范式情境中说明理由;这47条中最常见的是危及生命情境(20/47;42.6%),4条(4/47;8.5%)超出GRADE方法。作者认为,未来指南应说明此类配对的理由、在GRADE标准之外避免此类配对,并考虑对专家共识推荐(良好实践声明)使用单独措辞。
要点
- 681条重症指南推荐中强推荐215条(31.6%)、弱推荐345条(50.7%)、无强度121条(17.8%),推荐强度与证据质量正相关(ρ=0.66;p<0.0001)。
- 215条强推荐中69条(32.1%)与高/中等以外证据配对,其中22条(31.9%)为强推荐/专家共识,为GRADE方法所不鼓励。
- 47条强推荐/低或极低证据推荐中,最常见范式情境为危及生命情境(20/47;42.6%),4条(4/47;8.5%)超出GRADE方法。
- 证据质量以低/极低为主(298条;43.8%),高仅41条(6.0%)、中等151条(22.2%)、专家共识/无191条(28.1%)。
- 作者认为未来指南应说明强推荐与低质量证据配对的理由,避免GRADE标准外的配对,并考虑对专家共识推荐(良好实践声明)使用单独措辞。
适用人群与场景
- 纳入2011至2017年在线发布的美国重症医学会临床重症医学指南,以及拯救脓毒症运动、肾脏病改善全球结局组织、美国肠外肠内营养学会、美国感染病学会/美国胸科学会各自发布的指南,共15份文件、681条合格推荐。
研究设计与关键结果
- 研究类型为指南推荐的方法学评价;共15份文件、681条合格推荐;推荐强度:强推荐215条(31.6%)、弱推荐345条(50.7%)、无强度121条(17.8%);证据质量:高41条(6.0%)、中等151条(22.2%)、低/极低298条(43.8%)、专家共识/无191条(28.1%);推荐强度与证据质量正相关(ρ=0.66;p<0.0001)。
- 215条强推荐中69条(32.1%)与高/中等以外证据不一致配对;其中22条(31.9%)为强推荐/专家共识;47条(68.1%)为强推荐/低或极低证据,需在五种范式情境中说明理由。
- 47条强推荐/低或极低证据推荐中,最常见范式情境为危及生命情境(20/47;42.6%);4条(4/47;8.5%)超出GRADE方法。
证据类型、等级与局限
- 证据类型为指南方法学评价(对15份指南681条推荐的横断面分析);原文未报告证据等级或推荐强度分级;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来指南应说明强推荐与高/中等以外证据配对的理由,在GRADE标准之外避免此类配对,并考虑对专家共识推荐(良好实践声明)使用单独措辞,以改善清晰度和采纳。
指南或共识出处
- 重症医学指南:美国重症医学会2011至2017年在线发布的临床指南,以及拯救脓毒症运动、肾脏病改善全球结局组织、美国肠外肠内营养学会、美国感染病学会/美国胸科学会发布的指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We examined recommendations within critical care guidelines to describe the pairing patterns for strength of recommendation and quality of evidence. We further identified recommendations where the reported strength of recommendation was strong while the reported quality of evidence was not high/moderate and then assessed whether such pairings were within five paradigmatic situations offered by Grading of Recommendations Assessment, Development and Evaluation methodology to justify such pairings.
DATA SOURCES AND EXTRACTION: We identified all clinical critical care guidelines published online from 2011 to 2017 by the Society of Critical Care Medicine along with individual guidelines published by Surviving Sepsis Campaign, Kidney Disease Improving Global Outcomes, American Society for Parenteral and Enteral Nutrition, and the Infectious Disease Society of America/American Thoracic Society.
DATA SYNTHESIS: In all, 15 documents specifying 681 eligible recommendations demonstrated variation in strength of recommendation (strong n = 215 [31.6%], weak n = 345 [50.7%], none n = 121 [17.8%]) and in quality of evidence (high n = 41 [6.0%], moderate n = 151 [22.2%], low/very low n = 298 [43.8%], and Expert Consensus/none n = 191 [28.1%]). Strength of recommendation and quality of evidence were positively correlated (ρ = 0.66; p < 0.0001). Of 215 strong recommendations, 69 (32.1%) were discordantly paired with evidence other than high/moderate. Twenty-two of 69 (31.9%) involved Strong/Expert Consensus recommendations, a category discouraged by Grading of Recommendations Assessment, Development and Evaluation methodology. Forty-seven of 69 recommendations (68.1%) were comprised of Strong/Low or Strong/Very Low variation requiring justification within five paradigmatic scenarios. Among distribution in the five paradigmatic scenarios of Strong/Low and Strong/Very Low recommendations, the most common paradigmatic scenario was life threatening situation (n = 20/47; 42.6%). Four Strong/Low or Strong/Very Low recommendations (4/47; 8.5%) were outside Grading of Recommendations Assessment, Development and Evaluation methodology.
CONCLUSIONS: Among a large, diverse assembly of critical care guideline recommendations using Grading of Recommendations Assessment, Development and Evaluation methodology, the strength of evidence of a recommendation was generally associated with the quality of evidence. However, strong recommendations were not infrequently made in the absence of high/moderate quality of evidence. To improve clarity and uptake, future guideline statements may specify why such pairings were made, avoid such pairings when outside of Grading of Recommendations Assessment, Development and Evaluation criteria, and consider separate language for Expert Consensus recommendations (good practice statements).
参考来源
- Sims CR, Warner MA, Stelfox HT, et al. Above the GRADE: Evaluation of Guidelines in Critical Care Medicine. Crit Care Med. 2019. PMID: 30303840. doi:10.1097/CCM.0000000000003467
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。